Omnicell 

$49.34
14
+$0.84+1.72% 今天

统计

当日最高
50.14
当日最低
48.93
52周高点
55
52周低点
22.66
成交量
245,149
平均成交量
499,386
市值
2.21B
市盈率
78.07
股息率
-
股息
-

即将到来

财报

5Feb预期
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
下一步
0.14
0.3
0.45
0.6
预期EPS
0.49625
实际EPS
不适用

财务

1.13%利润率
有盈利
2019
2020
2021
2022
2023
2024
2.22B营收
25.06M净利润

分析师评级

$56.75平均目标价
最高预估为 60.00。
来自过去6个月内的 4 条评分。这不是投资建议。
买入
100%
持有
0%
卖出
0%

其他人也在关注

此列表基于在 Stock Events 上关注 OMCL 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Mountain View, California.
Show more...
首席执行官
Mr. Randall A. Lipps
员工
3620
国家
US
ISIN
US68213N1090

上市

0 Comments

分享你的想法

FAQ

Omnicell 今天的股价是多少?
OMCL 当前价格为 $49.34 USD,过去 24 小时上涨了 +1.72%。在图表上更密切关注 Omnicell 股价表现。
Omnicell 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Omnicell 的股票以代码 OMCL 进行交易。
Omnicell 的股价在上涨吗?
OMCL 股票较上周下跌 -1.49%,本月上涨 +9.81%,过去一年 Omnicell 上涨 +10.18%。
Omnicell 的市值是多少?
今天 Omnicell 的市值为 2.21B
Omnicell 下一次财报日期是什么时候?
Omnicell 将于 二月 05, 2026 发布下一次财报。
Omnicell 上一季度的财报怎么样?
OMCL 上季度财报为每股 0.51 USD,预估为 0.36 USD,带来 +40.69% 的意外。下季度预估财报为每股 不适用 USD。
Omnicell 去年的营收是多少?
Omnicell 去年的营收为 2.22BUSD。
Omnicell 去年的净利润是多少?
OMCL 去年的净收益为 25.06MUSD。
Omnicell 有多少名员工?
截至二月 02, 2026,公司共有3,620名员工。
Omnicell 属于哪个行业?
Omnicell从事于Health Care行业。
Omnicell 何时完成拆股?
Omnicell 最近没有进行任何拆股。
Omnicell 的总部在哪里?
Omnicell 的总部位于 US 的 Fort Worth。